Nanexa signs collaboration agreement with European animal health company
Pressrelease
Uppsala 1st August 2018
Nanexa signs collaboration agreement with European animal health company
Nanexa has signed a collaboration agreement with the company ViroVet in Belgium to evaluate PharmaShell® together with one of their new drug substances for the treatment of a virus-related disease in cattle.
Nanexa launches its own product development of cancer drugs for indications with high medical needs and growing market potential.
Pressrelease
Uppsala 26th June 2018
Nanexa launches its own product development of cancer drugs for indications with high medical needs and growing market potential.
Nanexa’s Board of Directors has decided to start product development for a product based on Nanexa’s drug delivery platform PharmaShell®.
